Results 11 to 20 of about 79,377 (290)

Late thrombosis of coronary bare-metal stent: Case report [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2006
Stent thrombosis remains the primary cause of death after percutaneous coronary interventions (PCI). Despite modern concepts of PCI, stent thrombosis occurs in 0.5% -2% of elective procedures and even 6% of patients with the acute coronary syndrome (ACS).
Apostolović Svetlana, Perišić Zoran, Tomašević Miloje, Stanković Goran, Pavlović Milan, Šalinger-Martinović Sonja   +5 more
doaj   +1 more source

Stent thrombosis revisited [PDF]

European Heart Journal, 1996
The choice of antithrombotic regimes after stent implantation has increased. Complication rates have improved and in-hospital stay is reduced with the less aggressive regimes. For de novo stenting in large vessels with a good result, ticlopidine plus aspirin or even aspirin alone appears attractive.
A H, Gershlick, R K, Aggarwal
openaire   +2 more sources

Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study. [PDF]

PLoS ONE, 2014
The widespread use of coronary stents has exposed a growing population to the risk of stent thrombosis, but the importance in terms of risk of ST-segment elevation myocardial infarctions (STEMIs) remains unclear.We studied five years follow-up data for 2,
Søren Lund Kristensen, Anders M Galløe, Leif Thuesen, Henning Kelbæk, Per Thayssen, Ole Havndrup, Peter Riis Hansen, Niels Bligaard, Kari Saunamäki, Anders Junker, Jens Aarøe, Ulrik Abildgaard, Jørgen L Jeppesen   +12 more
doaj   +1 more source

Coronary Stent Thrombosis in COVID-19 Patients: A Systematic Review of Cases Reported Worldwide

Viruses, 2022
Approximately 5 million percutaneous coronary interventions are performed worldwide annually. Therefore, stent-related complications pose a serious public health concern.
Wojciech Jan Skorupski, Marek Grygier, Maciej Lesiak, Marta Kałużna-Oleksy   +3 more
doaj   +1 more source

The value of routine blood test parameters obtained at admission to predict acute stent thrombosis in patients with st-segment elevation myocardial infarction

Medicine Science, 2020
The purpose of this study was to investigate whether biochemical parameters on admission can predict the development of acute stent thrombosis within 24 hours of presentation in patients with ST-segment elevation myocardial infarction (STEMI) who ...
Yusuf Cekici
doaj   +1 more source

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature

Heart Views, 2011
Very late stent thrombosis occurs more frequently with drug-eluting stents and tends to occur despite dual antiplatelet therapy or after long periods of clopidogrel discontinuation.
Prashanth Panduranga, Mohammed Al-Mukhaini   +1 more
doaj   +1 more source

Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. [PDF]

, 2017
BackgroundElevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown.Methods and resultsBaseline demographics and 2-year MACE were ...
Ang, Lawrence, Behnamfar, Omid, Lin, Felice, Mahmud, Ehtisham, Palakodeti, Samhita, Patel, Mitul P, Pourdjabbar, Ali, Reeves, Ryan R   +7 more
core   +1 more source

Stent thrombosis in patients with drug-eluting stents and bioresorbable vascular scaffolds [PDF]

, 2018
The percutaneous coronary intervention has undergone rapid evolution over the last 40 years and has become one of the most widely performed medical procedures.
Kerkmeijer, L.S. (Laura S.), Tenekecioglu, E. (Erhan), Wykrzykowska, J.J. (Joanna)   +2 more
core   +10 more sources

Acute myocardial infarction due to stent thrombosis associated with coronary pseudoaneurysm: a percutaneous approach to a complex case. [PDF]

Postepy Kardiol Interwencyjnej
Granchietti AG, Pennesi M, Nardi G, Cecchi E.   +3 more
europepmc   +3 more sources

Bivalirudin started during emergency transport for primary PCI. [PDF]

, 2013
BACKGROUND: Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI).
Berg, J. van den, Bernstein, D., Clayton, T., Clemmensen, P., Coste, P., Deliargyris, E.N., Eggink, G.J., et al., Goldstein, P., Grunsven, P. van, Hamm, C.W., Hamon, M., Hof, A. van't, Huber, K., Lapostolle, F., Nef, H., Nibbe, L., Orto, M. Campo dell', Pocock, S., Prats, J., Schuette, D., Soulat, L., Steg, P.G., Steinmetz, J., Verheugt, F.W.A., Zeymer, U.   +25 more
core   +1 more source